%0 Case Reports
%T Ocriplasmin in the Treatment of Vitreomacular Traction in a Patient with Central Retinal Vein Occlusion: A Case Report.
%A Rosati A
%A Esposito RA
%A Mannino G
%A Scuderi G
%J Case Rep Ophthalmol
%V 9
%N 2
%D May-Aug 2018
%M 30140222
暂无%R 10.1159/000491487
%X <B>OBJECTIVE: </B>To investigate the efficacy of intravitreal injection of ocriplasmin (JETREA®) in the treatment of vitreomacular traction (VMT).<BR><B>METHODS: </B>An 81-year-old man with VMT associated with central retinal vein occlusion in his left eye, was treated with a single intravitreal injection of ocriplasmin (25 μg). Best corrected visual acuity (BCVA), ocular fundus, and optical coherence tomography were examined before and after treatment.<BR><B>RESULTS: </B>Complete release of VMT produced a reduction of central macular thickness, ranging from 459 to 141 μm. BCVA remained stable.<BR><B>CONCLUSIONS: </B>The use of ocriplasmin was effective in the treatment of VMT. Ocriplasmin represents a valid alternative to conventional pars plana vitrectomy.